4.3 Article

Association of patient copayment and medication adherence in systemic lupus erythematosus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study

Shirley P. P. Huang et al.

Summary: This study aimed to examine the clinical burden, healthcare resource utilization, and healthcare costs for patients with systemic lupus erythematosus (SLE) in the USA before they were diagnosed with end-stage kidney disease (ESKD) within a period of 12-60 months. The findings showed an increase in clinical burden, healthcare resource utilization, and healthcare costs as the ESKD diagnosis approached.

RHEUMATOLOGY AND THERAPY (2023)

Editorial Material Pharmacology & Pharmacy

Proportion of days covered as a measure of medication adherence

Jennifer Loucks et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2022)

Article Rheumatology

Impact of Antimalarial Adherence on Mortality Among Patients With Newly Diagnosed Systemic Lupus Erythematosus: A Population-Based Cohort Study

M. Rashedul Hoque et al.

Summary: Adherence to antimalarial therapy is significantly associated with a lower risk of premature mortality among patients with incident systemic lupus erythematosus (SLE).

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff

Kai Sun et al.

Summary: This study aims to explore barriers to adherence to immunosuppressive medications among minority SLE patients. Through in-depth interviews with patients and healthcare providers, cost, side effects, logistic and intrinsic barriers were identified as major barriers to adherence. The findings suggest that interventions targeting logistics and motivation, while addressing individual differences, may have the greatest impact.

ARTHRITIS CARE & RESEARCH (2022)

Review Rheumatology

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

Alina Dima et al.

Summary: Hydroxychloroquine (HCQ) has shown multiple benefits in the treatment of systemic lupus erythematosus (SLE), including decreasing disease activity, preventing flare-ups, lowering the need for long-term glucocorticoid use, and improving long-term outcomes such as damage accrual and mortality. It also has positive effects on pregnancy and breastfeeding, and may delay progression to SLE in individuals with positive antinuclear antibodies.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2022)

Review Rheumatology

COVID-19 in patients with systemic lupus erythematosus: A systematic review

Xue-Lei Fu et al.

Summary: The study aimed to review the literature and identify the epidemiology of systemic lupus erythematosus (SLE) and coronavirus disease 2019 (COVID-19), the clinical characteristics of SLE patients with COVID-19, the treatment of COVID-19 in SLE patients, and the impact of the COVID-19 pandemic on SLE patients. A systematic review of 52 studies revealed that the prevalence of COVID-19 infection in SLE patients ranged from 0.0% to 18.1%, with hospitalization rates ranging from 0.24% to 10.6%. COVID-19 infection was found to mimic SLE flare, and hydroxychloroquine (HCQ) was ineffective in preventing COVID-19. SLE patients with COVID-19 faced challenges in healthcare access, financial constraints, and psychological distress during the pandemic.
Article Rheumatology

P110 Adherence with mycophenolate mofetil in connective tissue disorders

Aarti Chauhan et al.

RHEUMATOLOGY (2022)

Article Rheumatology

Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus

Joyce C. Chang et al.

Summary: By studying children with systemic lupus erythematosus (SLE) in the United States, this research examined the adherence to hydroxychloroquine and immunosuppressant medications. It found that assessing immunosuppressant adherence concurrently adds value to hydroxychloroquine adherence assessments and that prescription claims-based immunosuppressant adherence measures are predictive of acute care utilization.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Article Rheumatology

Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States

Irene B. Murimi-Worstell et al.

Summary: This study quantified healthcare utilization and costs by disease severity for patients with systemic lupus erythematosus (SLE) in the United States. The results showed that patients with severe SLE had higher annual costs compared to patients with moderate or mild SLE, across all service categories. Utilization patterns remained generally similar over the study years, with a high percentage of patients having at least one hospitalization, ED visit, outpatient visit, and prescription drug use annually.

JOURNAL OF RHEUMATOLOGY (2021)

Article Rheumatology

Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance Program

Deeba Minhas et al.

Summary: The study found that systemic lupus erythematosus (SLE) patients were more likely than controls to report cost-related prescription nonadherence, including skipping doses, taking less medicine, and delaying filling prescriptions, yet less than one in four patients asked providers for lower cost medications. Disparities were found in association with income, race, and health insurance status, but the main findings persisted after adjusting for these and other variables in multivariable models.

ARTHRITIS CARE & RESEARCH (2021)

Review Rheumatology

Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries

Katherine P. Pryor et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)

Article Medicine, General & Internal

High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete

Irini Gergianaki et al.

Summary: This study analyzed the comorbidity patterns of patients with systemic lupus erythematosus, revealing a high prevalence of both physical and mental comorbidities among these patients. Sociodemographic and clinical factors were independently associated with the presence of multimorbidity. The results emphasize the need for integrated care to optimize outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling

Caroline E. Sloan et al.

Summary: A survey study on US physicians revealed that many struggle to accurately estimate patients' out-of-pocket costs, even with access to insurance plans. This highlights the need for increased price transparency and simpler insurance cost-sharing mechanisms to facilitate informed cost conversations during prescribing.

JAMA NETWORK OPEN (2021)

Article Health Policy & Services

Estimating proportion of days covered (PDC) using real-world online medicine suppliers' datasets

David Prieto-Merino et al.

Summary: By applying three different PDC algorithms to real-world data from online pharmacies, the study found that these algorithms can assess pharmacy services and individual levels of adherence in real-world databases, especially in settings where people may switch between different suppliers of medicines.

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2021)

Article Health Care Sciences & Services

Association of Co-pay Elimination With Medication Adherence and Total Cost

Mingyan Cong et al.

Summary: The study found that elimination of co-pays for prescription drugs can lead to improvements in medication adherence and reductions in overall medical spending. Specifically, after the implementation of Zero Dollar Co-pay program, medication adherence increased among participants, while medical spending decreased significantly in comparison to the control group. The results suggest that benefit designs that eliminate co-pays for patients with chronic illnesses can positively impact medication adherence and reduce healthcare costs.

AMERICAN JOURNAL OF MANAGED CARE (2021)

Review Rheumatology

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Antonis Fanouriakis et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Review Pharmacology & Pharmacy

The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis

Caroline A. Walsh et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Medicine, General & Internal

Adherence to treatment in patients with systemic lupus erythematosus

Sebastian Prados-Moreno et al.

MEDICINA CLINICA (2018)

Review Rheumatology

Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review

Parvaneh Heidari et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)

Article Medicine, General & Internal

Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications

Sara Malo et al.

CURRENT MEDICAL RESEARCH AND OPINION (2017)

Article Pharmacology & Pharmacy

Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study

Scot H. Simpson et al.

ANNALS OF PHARMACOTHERAPY (2016)

Article Rheumatology

Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

Jinoos Yazdany et al.

ARTHRITIS & RHEUMATOLOGY (2015)

Article Health Policy & Services

The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims

Cindy Garris et al.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2015)

Article Rheumatology

Depression, Medication Adherence, and Service Utilization in Systemic Lupus Erythematosus

Laura J. Julian et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)

Article Medicine, General & Internal

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

Sudeep Karve et al.

CURRENT MEDICAL RESEARCH AND OPINION (2009)

Article Rheumatology

Health Care Costs and Costs Associated With Changes in Work Productivity Among Persons With Systemic Lupus Erythematosus

Pantelis Panopalis et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)

Article Rheumatology

Compliance With Biologic Therapies for Rheumatoid Arthritis: Do Patient Out-of-Pocket Payments Matter?

S. Curkendall et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)

Article Health Care Sciences & Services

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

HD Quan et al.

MEDICAL CARE (2005)

Article Rheumatology

Eligibility, utilization, and costs in a California Medicaid lupus population

MB Nichol et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)

Article Medicine, General & Internal

Physicians' attitudes about prescribing and knowledge of the costs of common medications

S Reichert et al.

ARCHIVES OF INTERNAL MEDICINE (2000)